Clinical trials in White Plains, NY

15 recruiting studies have a site in or near White Plains, NY, New York.

Top conditions here

All conditions

Showing 15 of 15 studies

RecruitingPhase 3NCT04267848

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Sponsor: National Cancer Institute (NCI)

Auburn, NY · Bay Shore, NY · Brooklyn, NY · +1147 more sites

RecruitingPhase 3NCT07513376

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

Sponsor: Merck Sharp & Dohme LLC

Albany, NY · Syracuse, NY · White Plains, NY · +21 more sites

RecruitingPhase 3NCT07365995

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

Sponsor: BioNTech SE

Albany, NY · White Plains, NY · +19 more sites

RecruitingPhase 2 / Phase 3NCT06712316

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)

Sponsor: BioNTech SE

Poughkeepsie, NY · Stony Brook, NY · White Plains, NY · +50 more sites

RecruitingPhase 3NCT06712355

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Sponsor: BioNTech SE

New York, NY · White Plains, NY · +34 more sites

RecruitingPhase 3NCT07144280

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Sponsor: Pfizer

The Bronx, NY · White Plains, NY · +239 more sites

RecruitingPhase 3NCT07228832

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Sponsor: Summit Therapeutics

Mineola, NY · New York, NY · Rochester, NY · +109 more sites

RecruitingPhase 3NCT05879926

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Sponsor: NRG Oncology

Bay Shore, NY · Bronxville, NY · Brooklyn, NY · +1223 more sites

RecruitingNot applicableNCT05081596

A Primary Care-Based Psychosocial Intervention To Improve Cognitive & Depression Outcomes in Older Adults With MCI & Early Stage AD

Sponsor: Weill Medical College of Cornell University

White Plains, NY

RecruitingPhase not listedNCT07379827

Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)

Sponsor: Bristol-Myers Squibb

Buffalo, NY · Monsey, NY · Rochester, NY · +52 more sites

RecruitingPhase 1 / Phase 2NCT06330064

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Sponsor: Daiichi Sankyo

New York, NY · Westbury, NY · +15 more sites

RecruitingNot applicableNCT07434479

A Virtual Reality Mindfulness Application for Aggression in Schizophrenia

Sponsor: Manhattan Psychiatric Center

New York, NY · White Plains, NY

RecruitingPhase not listedNCT05236114

GEMINI-NSCLC: NSCLC Biomarker Study

Sponsor: Tempus AI

Albany, NY · East Syracuse, NY · Ithaca, NY · +55 more sites

RecruitingNot applicableNCT05447689

Mind-Body Skills Group for Graduate Students

Sponsor: Weill Medical College of Cornell University

White Plains, NY

RecruitingPhase 2NCT06502964

Study of ALTO-101 in Patients With Schizophrenia

Sponsor: Alto Neuroscience

New York, NY · +11 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.